Jason W Denbo1, Morgan Bruno2, Whitney Dewhurst2, Michael P Kim2, Ching-Wei Tzeng2, Thomas A Aloia2, Jose Soliz3, Barbara Bryce Speer3, Jeffrey E Lee2, Matthew H G Katz4. 1. Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; Department of Surgery, University of Minnesota, Minneapolis, MN. 2. Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. 3. Department of Anesthesia, University of Texas MD Anderson Cancer Center, Houston, TX. 4. Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: mhgkatz@mdanderson.org.
Abstract
BACKGROUND: Postoperative pancreatic fistula is associated with adverse events, increased duration of stay and hospital costs. We developed perioperative care pathways stratified by postoperative pancreatic fistula risk with the aims of minimizing variations in care, improving quality, and decreasing costs. STUDY DESIGN: Three unique risk-stratified pancreatectomy clinical pathways-low-risk pancreatoduodenectomy, high-risk pancreatoduodenectomy, and distal pancreatectomy were developed and implemented. Consecutive patients treated after implementation of the risk-stratified pancreatectomy clinical pathways were compared with patients treated immediately prior. Duration of stay, rates of perioperative adverse effects, discharge disposition, and hospital readmission, as well as the associated costs of care, were evaluated. RESULTS: The median hospital stay after pancreatectomy decreased from 10 to 6 days after implementation of the risk-stratified pancreatectomy clinical pathways (P < .001), and the median cost of index hospitalization decreased by 22%. Decreased changes in median hospital stay and costs of hospitalization were observed in association with low-risk pancreatoduodenectomy (P < .05) and distal pancreatectomy (P < .05), but not high-risk pancreatoduodenectomy. The rates of 90-day adverse events, grade B/C postoperative pancreatic fistula, discharge to a facility other than home, or readmission did not change after implementation. CONCLUSION: Implementation of risk-stratified pancreatectomy clinical pathways decreased median stay and cost of index hospitalization after pancreatectomy without unfavorably affecting rates of perioperative adverse events or readmission, or discharge disposition. Outcomes were most favorably improved for low-risk pancreatoduodenectomy and distal pancreatectomy. Additional work is necessary to decrease the rate of postoperative pancreatic fistula, minimize variability, and improve outcomes after high-risk pancreatoduodenectomy. Published by Elsevier Inc.
BACKGROUND:Postoperative pancreatic fistula is associated with adverse events, increased duration of stay and hospital costs. We developed perioperative care pathways stratified by postoperative pancreatic fistula risk with the aims of minimizing variations in care, improving quality, and decreasing costs. STUDY DESIGN: Three unique risk-stratified pancreatectomy clinical pathways-low-risk pancreatoduodenectomy, high-risk pancreatoduodenectomy, and distal pancreatectomy were developed and implemented. Consecutive patients treated after implementation of the risk-stratified pancreatectomy clinical pathways were compared with patients treated immediately prior. Duration of stay, rates of perioperative adverse effects, discharge disposition, and hospital readmission, as well as the associated costs of care, were evaluated. RESULTS: The median hospital stay after pancreatectomy decreased from 10 to 6 days after implementation of the risk-stratified pancreatectomy clinical pathways (P < .001), and the median cost of index hospitalization decreased by 22%. Decreased changes in median hospital stay and costs of hospitalization were observed in association with low-risk pancreatoduodenectomy (P < .05) and distal pancreatectomy (P < .05), but not high-risk pancreatoduodenectomy. The rates of 90-day adverse events, grade B/C postoperative pancreatic fistula, discharge to a facility other than home, or readmission did not change after implementation. CONCLUSION: Implementation of risk-stratified pancreatectomy clinical pathways decreased median stay and cost of index hospitalization after pancreatectomy without unfavorably affecting rates of perioperative adverse events or readmission, or discharge disposition. Outcomes were most favorably improved for low-risk pancreatoduodenectomy and distal pancreatectomy. Additional work is necessary to decrease the rate of postoperative pancreatic fistula, minimize variability, and improve outcomes after high-risk pancreatoduodenectomy. Published by Elsevier Inc.
Authors: Eugene P Kennedy; Ernest L Rosato; Patricia K Sauter; Laura M Rosenberg; Cataldo Doria; Ignazio R Marino; Karen A Chojnacki; Adam C Berger; Charles J Yeo Journal: J Am Coll Surg Date: 2007-05 Impact factor: 6.113
Authors: Alejandro Recart; David Duchene; Paul F White; Tojo Thomas; D Brooke Johnson; Jeffrey A Cadeddu Journal: J Endourol Date: 2005-12 Impact factor: 2.942
Authors: G A Porter; P W Pisters; C Mansyur; A Bisanz; K Reyna; P Stanford; J E Lee; D B Evans Journal: Ann Surg Oncol Date: 2000-08 Impact factor: 5.344
Authors: Jason W Denbo; Rebecca S Slack; Morgan Bruno; Jordan M Cloyd; Laura Prakash; Jason B Fleming; Michael P Kim; Thomas A Aloia; Jean-Nicolas Vauthey; Jeffrey E Lee; Matthew H G Katz Journal: J Gastrointest Surg Date: 2017-01-03 Impact factor: 3.452
Authors: Kristin N Kelly; James C Iannuzzi; Aaron S Rickles; John R T Monson; Fergal J Fleming Journal: J Gastrointest Surg Date: 2013-09-25 Impact factor: 3.452
Authors: Linda W Ma; Ismael Dominguez-Rosado; Renee L Gennarelli; Peter B Bach; Mithat Gonen; Michael I D'Angelica; Ronald P DeMatteo; T Peter Kingham; Murray F Brennan; William R Jarnagin; Peter J Allen Journal: Ann Surg Date: 2017-01 Impact factor: 12.969
Authors: Michał Pędziwiatr; Piotr Małczak; Magdalena Pisarska; Piotr Major; Michał Wysocki; Tomasz Stefura; Andrzej Budzyński Journal: Langenbecks Arch Surg Date: 2017-05-09 Impact factor: 3.445
Authors: Emily Z Keung; Elliot A Asare; Yi-Ju Chiang; Laura R Prakash; Nikita Rajkot; Keila E Torres; Kelly K Hunt; Barry W Feig; Janice N Cormier; Christina L Roland; Matthew H G Katz; Jeffrey E Lee; Ching-Wei D Tzeng Journal: Am J Surg Date: 2019-11-30 Impact factor: 2.565
Authors: Timothy P DiPeri; Timothy E Newhook; Elsa M Arvide; Whitney L Dewhurst; Morgan L Bruno; Yun Shin Chun; Hop S Tran Cao; Jeffrey E Lee; Jean-Nicolas Vauthey; Ching-Wei D Tzeng Journal: J Am Coll Surg Date: 2022-04-11 Impact factor: 6.532
Authors: Russell G Witt; Timothy E Newhook; Laura R Prakash; Morgan L Bruno; Elsa M Arvide; Whitney L Dewhurst; Naruhiko Ikoma; Jessica E Maxwell; Michael P Kim; Jeffrey E Lee; Matthew H G Katz; Ching-Wei D Tzeng Journal: J Surg Res Date: 2022-03-17 Impact factor: 2.417
Authors: Huiyu Deng; Zahra Eftekhari; Cameron Carlin; Jula Veerapong; Keith F Fournier; Fabian M Johnston; Sean P Dineen; Benjamin D Powers; Ryan Hendrix; Laura A Lambert; Daniel E Abbott; Kara Vande Walle; Travis E Grotz; Sameer H Patel; Callisia N Clarke; Charles A Staley; Sherif Abdel-Misih; Jordan M Cloyd; Byrne Lee; Yuman Fong; Mustafa Raoof Journal: JAMA Netw Open Date: 2022-05-02
Authors: Casey J Allen; Nikhil G Thaker; Laura Prakash; Brittany C Kruse; Thomas W Feeley; Robert S Kaplan; Ryan Huey; Steven J Frank; Thomas A Aloia; Vijaya Gottumukkala; Matthew H G Katz Journal: Ann Surg Date: 2021-01-01 Impact factor: 13.787
Authors: Bradford J Kim; Elsa M Arvide; Cameron Gaskill; Allison N Martin; Yoshikuni Kawaguchi; Yi-Ju Chiang; Whitney L Dewhurst; Teresa L Phan; Hop S Tran Cao; Yun Shin Chun; Matthew H G Katz; Jean Nicolas Vauthey; Ching-Wei D Tzeng; Timothy E Newhook Journal: Surg Open Sci Date: 2022-05-08